Trial Profile
A 6-Week, Multicenter, Rater-Blind, Randomized, Risperidone-Controlled Study to Evaluate the Efficacy and Safety of Seroquel (Quetiapine Fumarate) in the Treatment of Chinese Han Patients With Schizophrenia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2013
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 01 Oct 2012 Primary endpoint 'Positive-and-Negative-Syndrome-Scale' has not been met.
- 17 Sep 2012 Results published in the Current Medical Research and Opinion.
- 14 Jun 2010 Status changed from recruiting to completed added as reported by ClinicalTrials.gov.